Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
about
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsHepatitis C Virus, Insulin Resistance, and SteatosisMetabolic alterations and hepatitis C: From bench to bedsideHepatitis C virus infection and type 1 and type 2 diabetes mellitusMetabolic factors and chronic hepatitis C: a complex interplayFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVHyperferritinemia and hyperuricemia may be associated with liver function abnormality in obese adolescentsMetabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients.Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionSerum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseasesLiver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.Insulin resistance and chronic liver disease.Coinfection with HIV-1 and HCV--a one-two punch.Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trialComparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicityImpact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin actionThe impact of host factors on management of hepatitis C virus.IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesInsulin sensitivity and variability in hepatitis C virus infection using direct measurementImpact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection.Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.Hepatitis C and diabetes: the inevitable coincidence?Interaction between hepatitis C virus and metabolic factors.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Metabolic alterations and chronic hepatitis C: treatment strategies.Use of HOMA-IR in hepatitis C.The predictive value of steatosis in hepatitis C virus infection.Cardiovascular diseases and HCV infection: a simple association or more?The impact of hepatitis C burden: an evidence-based approach.Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityOptimal management of patients with chronic hepatitis C and comorbidities.Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis.The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population.
P2860
Q26745576-414BF0C3-767B-4411-AF96-B26737B73D14Q26751755-63D023BA-1859-4829-86A1-A9AD49025CF8Q26773261-EEBFC979-F461-4F01-AE76-8904AF2AD979Q26829202-9F8A6105-57E8-41E2-98B5-9AD14338F2AAQ27011787-AE9F9B9B-49C3-48A8-83B5-0CF3E1C528FBQ28079826-C36B771C-F7A7-4B74-86C9-23D6A4999196Q28484682-4281BE92-2CC1-4D2C-8C3C-09B4D144F25DQ30369757-BB0620D9-D155-452B-8EE5-CC174DD232A2Q33577482-79F4494B-2DF6-4DAF-9AAC-02320C455C15Q33731308-13E9907C-98BA-42B4-B97A-B8BF3497C274Q33958775-031B04F5-5077-4F49-B849-0B52070DC0B0Q34263370-46D8FD0E-1F96-4B1B-B402-4D16F3D80E16Q34507283-EF3218C7-65D4-44BD-B1A1-37DC5F6C85AAQ34943906-C85D1F81-9135-484E-8E7A-758C329016B1Q35073012-6D0B9ACF-3789-48D3-BF29-07DF23E6671FQ35137038-0A044959-4216-4C5D-8590-FC76BD57FD27Q35142681-098B68C4-9F05-4BC2-85A9-B4AED223EA33Q35346377-D1079316-7397-4BAA-A4D4-2F994201FD9EQ35898216-F54ACCD2-8BB1-40A8-A713-F7AC2DCB9CCEQ35990066-A4289234-9D02-4C08-BB57-3B914E8B0AA0Q36248186-F3DEE028-5040-412A-909F-894BE839EE29Q36561567-F569307B-214A-4A97-A6A4-B5073F765659Q36592257-BD398B30-0E68-4944-9714-91805FDF59E0Q36734252-9CEF04F4-ADD3-40B8-A88C-FF201DC56739Q37016775-2D42EA7B-2F77-46BD-8316-B682133FC7EBQ37432092-7FEAE4A7-7681-467E-8843-62CA61C3443FQ37654443-99FD85F5-F26F-4CC9-B23F-C4B629B54998Q37685491-4112F193-B4F3-411C-8739-4424D8ED570EQ37924816-99846AA6-99C5-4B88-B151-F54A0EC9C02FQ37931383-05E989A0-1156-40F5-B3F0-13A7C789C93BQ38085061-5BCB92C5-38FE-457B-9DE8-B2716A1FA835Q38167953-BB68110D-B361-4099-88EC-74EB017B8FCBQ38181631-E87F048E-D51A-4FEC-8C8D-636F5146D3B7Q38198618-859E8614-2755-4D68-AD34-40DAF44FC2EBQ38295819-99B0DDEA-F4B0-4BAA-8AD2-B1614F0F3DD1Q38542209-2A9B60CB-0DC7-47DB-9DE2-E4196DFF60BCQ38572687-2F949CB2-322D-48FB-A2D7-B33804E63B60Q38660769-F682DDCB-D34E-4893-B352-A5BA7D5A464AQ38726664-38307ED7-8D95-44B7-8931-2D9237B88C2CQ38745903-C6B16BAC-9B46-47E9-B9B2-033C680A4326
P2860
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@en
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@nl
type
label
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@en
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@nl
prefLabel
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@en
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@nl
P2093
P2860
P50
P1476
Insulin resistance and diabete ...... with genotype 1 HCV infection.
@en
P2093
Calogero Cammà
Fatima Massenti
Giuseppe Tarantino
Nicola Alessi
Rosalia Caldarella
Vito Di Marco
P2860
P304
P356
10.1111/J.1572-0241.2008.01813.X
P407
P577
2008-05-01T00:00:00Z